Pregnancy in a patient with glycogen storage disease type Ia (von Gierke disease): case report and management strategy

IF 2.7
AJOG global reports Pub Date : 2026-08-01 Epub Date: 2026-07-09 DOI:10.1016/j.xagr.2026.100672
Camila Andrea Camargo Rodríguez MD, Cristian Rolando Avellaneda-Garnica MD, Rafael Leonardo Aragón-Mendoza MD, Yaisa Maritza Castaño Toro MD, David Rodriguez Buritica MD
{"title":"Pregnancy in a patient with glycogen storage disease type Ia (von Gierke disease): case report and management strategy","authors":"Camila Andrea Camargo Rodríguez MD,&nbsp;Cristian Rolando Avellaneda-Garnica MD,&nbsp;Rafael Leonardo Aragón-Mendoza MD,&nbsp;Yaisa Maritza Castaño Toro MD,&nbsp;David Rodriguez Buritica MD","doi":"10.1016/j.xagr.2026.100672","DOIUrl":null,"url":null,"abstract":"<div><div>Glycogen storage disease type I (GSDI) is caused by biallelic pathogenic variants in the gene encoding the glucose-6-phosphatase complex. Deficiency of this enzyme in the liver, kidneys, and intestines leads to glycogen accumulation in these organs and, consequently, to inadequate glucose production due to impaired glycogenolysis and gluconeogenesis. The condition is rare, and only a limited number of cases have been reported in pregnant women with favorable maternal and perinatal outcomes. This is partly because GSDI has been associated with significant morbidity, including maternal metabolic disturbances, renal and/or hepatic disease, preeclampsia, and fetal growth restriction, among other complications. We present the case of a 23-year-old woman with a diagnosis of GSDI who was evaluated at 19 weeks of pregnancy and managed according to a multidisciplinary protocol, resulting in a favorable perinatal outcome. This case highlights the need for clinical management protocols with specific strategies during the preconception period, pregnancy, delivery, and postpartum, aimed at preventing complications and improving maternal and perinatal outcomes.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"6 3","pages":"Article 100672"},"PeriodicalIF":2.7000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJOG global reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666577826000705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/9 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Glycogen storage disease type I (GSDI) is caused by biallelic pathogenic variants in the gene encoding the glucose-6-phosphatase complex. Deficiency of this enzyme in the liver, kidneys, and intestines leads to glycogen accumulation in these organs and, consequently, to inadequate glucose production due to impaired glycogenolysis and gluconeogenesis. The condition is rare, and only a limited number of cases have been reported in pregnant women with favorable maternal and perinatal outcomes. This is partly because GSDI has been associated with significant morbidity, including maternal metabolic disturbances, renal and/or hepatic disease, preeclampsia, and fetal growth restriction, among other complications. We present the case of a 23-year-old woman with a diagnosis of GSDI who was evaluated at 19 weeks of pregnancy and managed according to a multidisciplinary protocol, resulting in a favorable perinatal outcome. This case highlights the need for clinical management protocols with specific strategies during the preconception period, pregnancy, delivery, and postpartum, aimed at preventing complications and improving maternal and perinatal outcomes.
妊娠合并Ia型糖原储存病(von Gierke病)1例报告及处理策略
糖原储存病I型(GSDI)是由编码葡萄糖-6-磷酸酶复合物基因的双等位致病变异引起的。肝脏、肾脏和肠道中缺乏这种酶会导致糖原在这些器官中积累,从而由于糖原分解和糖异生受损而导致葡萄糖产生不足。这种情况是罕见的,只有有限数量的病例报道了孕妇良好的孕产妇和围产期结局。部分原因是GSDI与显著的发病率相关,包括母体代谢紊乱、肾脏和/或肝脏疾病、先兆子痫、胎儿生长受限以及其他并发症。我们报告了一名23岁的女性,她被诊断为GSDI,在怀孕19周时进行了评估,并根据多学科协议进行了管理,结果是良好的围产期结果。该病例强调需要在孕前、妊娠、分娩和产后制定具有特定策略的临床管理方案,旨在预防并发症并改善孕产妇和围产期结局。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AJOG global reports
AJOG global reports Endocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Perinatology, Pediatrics and Child Health, Urology
CiteScore
1.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书